Grant: Engage Plus Grants Program
McGill University
$12,500.00
Biochemical profiling and activity of the botanical extract CELEXT07
EF 2017-18
Résumé
The mission and vision of Mondias Naturals Inc (MNI) is to commercialize evidence-based botanicalantimicrobial products for the residential, organic and commercial agricultural markets. Mondias has identifiedseveral herb extracts including CELEX07 that have antimicrobial activity. The previous NSERC-ENGAGEproposal (Application number 506182-16) was related to the needs of the industrial partner MNI to evaluate theuse of plant extracts as biopesticides against economically important diseases of plant crops. The main focus ofMNI was to obtain information on the minimum inhibitory concentration (MIC) of their botanical aqueousextracts (BE) prepared from plant roots of Chelidonium majus, (referred to as CELEX 07) against bacterial andfungal pathogens of tomato, tobacco and lettuce young plants, and compare CELEXT07 efficacy to existingbotanical extracts products found on the market (Yarrow and Thyme flower extracts). The results confirmedthat CELEXT07 applied as soil drench at the MIC 1% concentration showed growth stimulatory effect(increased plant height and weight) of tobacco and lettuce young plants compared to non-treated plants orplants treated with a combined dose of yarrow and CELEXT07. Armed with this knowledge, MNI is keen toaddress the following questions and objectives through NSERC Engage Plus: (1) What are the activemetabolites of CELEXT07 prepared from root and leaf organs (2) Identify the signatory metabolite groupresponsible for growth stimulation of plants (e.g., phytohormones) and increased resistance (e.g., phenolics)against selective pathogens. (3) Carry out large-scale greenhouse experiments toevaluate the efficacy ofCELEXT07 extracts from root vs. leaf for disease suppression of Botrytis cinerea and Xanthomonascampestris, the causal agents of grey mould and bacterial leaf spots on lettuce, respectively.The execution of the above objectives will provide Mondias Naturals Inc. an independent assessment andscientific evidence on the active metabolite in the botanical extract CELEX07 as well as the biotechnologicalpotential to develop a monotherapy-type line of formulations targeted for specific agricultural markets.
Programme
Engage Plus Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
521107-2017
Name nom
Jabaji, Suha
Department département
Plant Science
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
1
Nb partie
1
Application title
Biochemical profiling and activity of the botanical extract CELEXT07
Keyword
NSERC
Application summary
The mission and vision of Mondias Naturals Inc (MNI) is to commercialize evidence-based botanicalantimicrobial products for the residential, organic and commercial agricultural markets. Mondias has identifiedseveral herb extracts including CELEX07 that have antimicrobial activity. The previous NSERC-ENGAGEproposal (Application number 506182-16) was related to the needs of the industrial partner MNI to evaluate theuse of plant extracts as biopesticides against economically important diseases of plant crops. The main focus ofMNI was to obtain information on the minimum inhibitory concentration (MIC) of their botanical aqueousextracts (BE) prepared from plant roots of Chelidonium majus, (referred to as CELEX 07) against bacterial andfungal pathogens of tomato, tobacco and lettuce young plants, and compare CELEXT07 efficacy to existingbotanical extracts products found on the market (Yarrow and Thyme flower extracts). The results confirmedthat CELEXT07 applied as soil drench at the MIC 1% concentration showed growth stimulatory effect(increased plant height and weight) of tobacco and lettuce young plants compared to non-treated plants orplants treated with a combined dose of yarrow and CELEXT07. Armed with this knowledge, MNI is keen toaddress the following questions and objectives through NSERC Engage Plus: (1) What are the activemetabolites of CELEXT07 prepared from root and leaf organs (2) Identify the signatory metabolite groupresponsible for growth stimulation of plants (e.g., phytohormones) and increased resistance (e.g., phenolics)against selective pathogens. (3) Carry out large-scale greenhouse experiments toevaluate the efficacy ofCELEXT07 extracts from root vs. leaf for disease suppression of Botrytis cinerea and Xanthomonascampestris, the causal agents of grey mould and bacterial leaf spots on lettuce, respectively.The execution of the above objectives will provide Mondias Naturals Inc. an independent assessment andscientific evidence on the active metabolite in the botanical extract CELEX07 as well as the biotechnologicalpotential to develop a monotherapy-type line of formulations targeted for specific agricultural markets.